PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → L-Arginine→

L Arginine PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
74-79-3
Molecular formula
C6H14N4O2
Molecular weight
174.2 g/mol
Drug class
Proteinogenic amino acidurea-cycle intermediate and nitric-oxide precursor
Mechanism of action
Serves as a substrate for nitric oxide synthase, producing nitric oxide, and as an intermediate in the urea cycle. In urea-cycle disorders, exogenous arginine can support nitrogen disposal by promoting formation of ornithine and downstream urea-cycle intermediates, depending on the specific enzyme defect.
Indications / reported uses
  • Adjunctive management of selected urea-cycle disorders, including acute hyperammonaemia and chronic management, using formulation- and defect-specific regimens.
  • Used in selected mitochondrial disease presentations, including MELAS, under specialist clinical management.

Sources: https://www.ndf.gov.sg/about-drugs/active-ingredient/m01585/ · https://pmc.ncbi.nlm.nih.gov/articles/PMC3488504/ · https://pubmed.ncbi.nlm.nih.gov/11264451/ · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for L Arginine PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the L Arginine Permitted Daily Exposure (PDE) report (the L Arginine PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the L Arginine Occupational Exposure Limit (OEL) report (the L Arginine OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.